Dr. Angela Hirbe, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Studies Sarcoma
Studies Soft Tissue Sarcoma
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Angela Hirbe, M.D., Ph.D. is currently running
TNG908
for Solid Tumors
This trial is testing TNG908, an oral drug, in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these specific cancer cells grow. The study will see if this treatment can help slow down or stop the cancer.
Recruiting1 award Phase 1 & 210 criteria
ADI-PEG 20 + Ifosfamide + Radiotherapy
for Soft Tissue Sarcoma
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy.
Recruiting1 award Phase 1 & 2
More about Angela Hirbe, M.D., Ph.D.
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Angela Hirbe, M.D., Ph.D. has experience with
- Circulating Tumor DNA (ctDNA)
- Cabozantinib
- Nivolumab
- Ipilimumab
- ADI PEG20
- Ifosfamide
Breakdown of trials Angela Hirbe, M.D., Ph.D. has run
Sarcoma
Soft Tissue Sarcoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angela Hirbe, M.D., Ph.D. specialize in?
Angela Hirbe, M.D., Ph.D. focuses on Sarcoma and Soft Tissue Sarcoma. In particular, much of their work with Sarcoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Angela Hirbe, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Angela Hirbe, M.D., Ph.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Angela Hirbe, M.D., Ph.D. has studied deeply?
Yes, Angela Hirbe, M.D., Ph.D. has studied treatments such as Circulating Tumor DNA (ctDNA), Cabozantinib, Nivolumab.
What is the best way to schedule an appointment with Angela Hirbe, M.D., Ph.D.?
Apply for one of the trials that Angela Hirbe, M.D., Ph.D. is conducting.
What is the office address of Angela Hirbe, M.D., Ph.D.?
The office of Angela Hirbe, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.